[HTML][HTML] Eudragit®: A Versatile Family of Polymers for Hot Melt Extrusion and 3D Printing Processes in Pharmaceutics

J Dos Santos, GS da Silva, MC Velho, RCR Beck - Pharmaceutics, 2021 - mdpi.com
Eudragit® polymers are polymethacrylates highly used in pharmaceutics for the
development of modified drug delivery systems. They are widely known due to their …

[HTML][HTML] Raman spectroscopy in pharmaceutical product design

A Paudel, D Raijada, J Rantanen - Advanced drug delivery reviews, 2015 - Elsevier
Almost 100 years after the discovery of the Raman scattering phenomenon, related
analytical techniques have emerged as important tools in biomedical sciences. Raman …

A review of state-of-the-art on enabling additive manufacturing processes for precision medicine

A Awad, A Goyanes, AW Basit… - Journal of …, 2023 - asmedigitalcollection.asme.org
Precision medicine is an emerging healthcare delivery approach that considers variability
between patients, such as genetic makeups, in contrast to the current one-size-fits-all …

A review of pharmaceutical extrusion: Critical process parameters and scaling-up

J Thiry, F Krier, B Evrard - International journal of pharmaceutics, 2015 - Elsevier
Hot melt extrusion has been a widely used process in the pharmaceutical area for three
decades. In this field, it is important to optimize the formulation in order to meet specific …

Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations

B Démuth, ZK Nagy, A Balogh, T Vigh, G Marosi… - International journal of …, 2015 - Elsevier
Application of amorphous solid dispersions (ASDs) is considered one of the most promising
approaches to increase the dissolution rate and extent of bioavailability of poorly water …

The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity

DE Moseson, LS Taylor - International journal of pharmaceutics, 2018 - Elsevier
Hot melt extrusion (HME) can be used to produce amorphous solid dispersions (ASDs) at
temperatures below the drug's melting point if the drug and polymer exhibit melting point …

Process analytical techniques for hot-melt extrusion and their application to amorphous solid dispersions

P Hitzer, T Bäuerle, T Drieschner, E Ostertag… - Analytical and …, 2017 - Springer
Newly developed active pharmaceutical ingredients (APIs) are often poorly soluble in water.
As a result the bioavailability of the API in the human body is reduced. One approach to …

Characterization of pharmaceutically relevant materials at the solid state employing chemometrics methods

NL Calvo, RM Maggio, TS Kaufman - Journal of pharmaceutical and …, 2018 - Elsevier
The understanding of materials and processes is a requirement when it comes to build
quality into pharmaceutical products. This can be achieved through the development of …

Comparison of amorphous solid dispersions of spironolactone prepared by spray drying and electrospinning: The influence of the preparation method on the …

E Szabó, P Záhonyi, D Brecska, DL Galata… - Molecular …, 2020 - ACS Publications
This research aimed to compare two solvent-based methods for the preparation of
amorphous solid dispersions (ASDs) made up of poorly soluble spironolactone and poly …

[HTML][HTML] Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability

Z Wang, M Sun, T Liu, Z Gao, Q Ye, X Tan… - Asian Journal of …, 2019 - Elsevier
Co-amorphous solid dispersion (C-ASD) systems have attracted great attention to improve
the solubility of poorly soluble drugs, but the selection of an appropriate stabilizer to stabilize …